ClinicalTrials.govpublic full text
Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine Given as One Dose to Healthy Subjects Above 56 Years
infections, meningococcal
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 329589
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.